Zobrazeno 101 - 110
of 225
pro vyhledávání: '"Carmelo Rizzari"'
Autor:
Mariella Ferrari, Claudio Marcello Marzo, Luigi Cervo, Angelo Di Clemente, Federico Moro, Valentino Conter, Antonella Colombini, Ilaria Fuso Nerini, Massimo Zucchetti, Andrea Biondi, Carmelo Rizzari, Luca Porcu, Andrea Ballerini, Maurizio D'Incalci
Publikováno v:
Cancer chemotherapy and pharmacology. 79(6)
Purpose: Asparaginase (ASNase) is used to treat various hematological malignancies for its capacity to deplete asparagine (ASN) in serum and cerebrospinal fluid (CSF). Since the biological mechanisms underlying CSF asparagine depletion in humans are
Autor:
Andrea Pession, Carmelo Rizzari, Anna Leszl, Martina Pigazzi, Giuseppe Menna, Giuseppe Basso, Maria C. Putti, Valeria Bisio, Franco Locatelli, Claudia Tregnago, Matteo Zampini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6924dbff590c9656fe6bc7e4b9d7b75
http://hdl.handle.net/11577/3258545
http://hdl.handle.net/11577/3258545
Autor:
Rosanna Parasole, Giuseppe Basso, Martin Zimmermann, Anja Möricke, Andrea Teigler-Schlegel, Gunnar Cario, Andishe Attarbaschi, Andrea Pession, Concetta Micalizzi, Georg Mann, Luciana Vinti, Jörg Ritter, Nicola Santoro, Nicole Bodmer, Stefan S. Bielack, Leonid Karawajew, Franco Locatelli, Carmelo Rizzari, Maria Grazia Valsecchi, Valentino Conter, Bernd Gruhn, Daniela Silvestri, Oskar A. Haas, Maria Caterina Putti, Thomas Klingebiel, Andreas E. Kulozik, Andrea Biondi, Stefan Burdach, Martin Schrappe
To the editor: Reinduction therapy (also known as delayed intensification, DI) is an essential part of childhood acute lymphoblastic leukemia (ALL) treatment.[1][1],[2][2] In Berlin-Frankfurt-Munster (BFM) studies, it includes same/similar drugs as t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bc3da70e3265bf5c5cf17cb257a54d6
http://hdl.handle.net/11573/1481955
http://hdl.handle.net/11573/1481955
Autor:
Fiorina Casale, Elena Barisone, Gaetano La Barba, Anna Maria Testi, Daniela Silvestri, Maurizio Aricò, Concetta Micalizzi, Paolo Tamaro, Giuseppe Basso, Rosanna Parasole, Lucia Dora Notarangelo, Carmelo Rizzari, Maria Grazia Valsecchi, Ottavio Ziino, Valentino Conter, Antonella Colombini, Maria Caterina Putti, Marco Zecca, Luca Lo Nigro, Franco Locatelli, Giuseppe Masera, Andrea Biondi, Nicola Santoro, Gabriella Casazza, Andrea Pession
Publikováno v:
Blood. 123:1470-1478
The outcome of high-risk (HR) Acute Lymphoblastic Leukemia (ALL) patients enrolled in AIEOP-BFM ALL 2000 study (NCT00613457) in Italy is described. Overall, 1999 Philadelphia negative ALL patients entered the study. HR criteria were: minimal residual
Autor:
Jose-Luis Dapena, Barbara A. Degar, Fabrizio De Benedetti, Michael B. Jordan, Timothy P. Garrington, Carl E. Allen, Franco Locatelli, Walter Ferlin, Alexei A. Grom, Simone Cesaro, Martina Ahlmann, Franca Fagioli, Carmelo Rizzari, Anupama Rao, Cristina de Min, Maria Caterina Putti, Julián Sevilla, Maria Ballabio
Publikováno v:
Blood. 132:LBA-6
Introduction: Primary hemophagocytic lymphohistiocytosis (pHLH) is a rare, genetic life-threatening syndrome characterized by hyper-inflammation that is mainly driven by high production of interferon (IFN)-𝛾, leading to the development of fever, s
Autor:
Monica Lupi, Barbara Russo, Giovanna D'Amico, Maria Grazia Valsecchi, Geertruy te Kronnie, Franco Locatelli, Federica Portale, Giulia Cricrì, Andrea Biondi, Silvia Bresolin, Daniela Silvestri, Paolo Ubezio, Erica Dander, Carmelo Rizzari, Stefania Gaspari
Publikováno v:
Blood. 132:1296-1296
The bone marrow (BM) represents a peculiar microenvironment characterized by a high concentration of growth factors and cytokines necessary for hematopoiesis, that make it a sanctuary for leukemic cell homing, survival and proliferation. B-cell precu
Autor:
Martin Schrappe, Carmelo Rizzari, Antonella Colombini, Jan Starý, Valentino Conter, Anja Moericke
Publikováno v:
Current Opinion in Oncology. 25:S1-S9
Asparaginases are important agents used in the treatment of children with acute lymphoblastic leukemia (ALL). Three types of asparaginase are currently available: two are derived from Escherichia coli [native asparaginase and pegylated asparaginase (
Autor:
Andrea Pession, Concetta Micalizzi, Pietro Merli, Roberto Rondelli, Franca Fagioli, Martina Pigazzi, Carmelo Rizzari, Frida Rizzati, Barbara Buldini, Giuseppe Menna, Silvia Disarò, Nicola Santoro, Giuseppe Basso, Maria Caterina Putti, Marco Zecca, Riccardo Masetti, Franco Locatelli
Publikováno v:
British journal of haematology. 177(1)
In children with acute myeloid leukaemia (AML), assessment of initial treatment response is an essential prognostic factor; methods more sensitive than morphology are still under evaluation. We report on the measurement of minimal residual disease (M
Autor:
James A. Whitlock, Jose Sanchez de Toledo, Lewis B. Silverman, Inge M. van der Sluis, Carmelo Rizzari, André Baruchel, Veerle Mondelaers, Lynda M. Vrooman, Gabriele Escherich, Nicholas Goulden, Rob Pieters
Publikováno v:
Haematologica, 101(3), 279-285. Ferrata Storti Foundation
L-asparaginase is an integral component of therapy for acute lymphoblastic leukemia. However, asparaginase-related complications, including the development of hypersensitivity reactions, can limit its use in individual patients. Of considerable conce
Autor:
Marco Spinelli, Paola Cianci, Grazia Fazio, Sara Casagranda, Carmelo Rizzari, Angelo Selicorni, Gianni Cazzaniga
Publikováno v:
American journal of medical genetics. Part A. 173(2)
Baraitser-Winter malformation syndrome (BWMS), Fryns-Aftimos syndrome (FA), and craniofrontofacial syndromes (CFFs) have all been recently proposed to be part of the same phenotypic spectrum of Baraitser-Winter cerebrofrontofacial syndrome (BWCFF), w